ArticleTherapeutic advances in medical oncology2024

Molecular features and clinical outcomes of EGFR-mutated, MET-amplified non-small-cell lung cancer after resistance to dual-targeted therapy.

Mei-Mei Fang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.